SCHEMBL17155190

SCHEMBL17155190

CC(C)(C)OC(=O)CN1CCN(Cc2cc(N)ccn2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5C P41229 1/20 0.40
KDM4C Q9H3R0 1/20 0.40
CDK9 P50750 4/20 0.38
WNT1 P04628 1/20 0.37
GSK3B P49841 1/20 0.37
DYRK1A Q13627 1/20 0.37
KDM4E B2RXH2 4/20 0.37
ALDH1A1 P00352 4/20 0.37
NR1H2 P55055 1/20 0.36
CCNT1 O60563 3/20 0.36
TBK1 Q9UHD2 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
PPARG P37231 1/20 0.35
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM1 P11229 1/20 0.34
CHRM3 P20309 1/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4285303 0.86 TBK1 (0.47) KDM4EALDH1A1NR1H2TBK1CHRM2
SCHEMBL18406809 0.82 ALDH1A1 (0.39) KDM5CKDM4CKDM4EALDH1A1MEN1
SCHEMBL17986173 0.81 KDM4E (0.55) KDM4EALDH1A1NPSR1MEN1KMT2A
SCHEMBL27934400 0.81 KDM5C (0.40) KDM5CKDM4CKDM4EALDH1A1NPSR1
SCHEMBL28786467 0.79 KDM5C (0.41) KDM5CKDM4CWNT1GSK3BDYRK1A
SCHEMBL17152957 0.78 ALDH1A1 (0.42) KDM4EALDH1A1CHRM3MEN1KMT2A
SCHEMBL21448726 0.78 KDM4E (0.54) KDM4EALDH1A1NPSR1MEN1KMT2A
SCHEMBL12732683 0.77 LMNA (0.53) ALDH1A1
SCHEMBL9610831 0.77 LMNA (0.53) ALDH1A1
SCHEMBL17152793 0.76 MTNR1B (0.44) KDM4EALDH1A1NR1H2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170022201-A1 MACROCYLIC PYRIDINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2017-01-26 US disclosed
US-20170022201-A1 MACROCYLIC PYRIDINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2017-01-26 US disclosed
WO-2015150557-A1 MACROCYLIC PYRIDINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2015-10-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170022201-A1 MACROCYLIC PYRIDINE DERIVATIVES VPS26B, VPS4B, VPS28 KDM5C 3880/4885KDM4C 2606/4885CDK9 1354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.